Mediclinic International (Mediclinic International) LT-Debt-to-Total-Asset : 0.32 (As of Sep. 2022)

View and export this data going back to 2016. Start your Free Trial

What is Mediclinic International LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Mediclinic International's long-term debt to total assests ratio for the quarter that ended in Sep. 2022 was 0.32.

Mediclinic International's long-term debt to total assets ratio declined from Sep. 2021 (0.34) to Sep. 2022 (0.32). It may suggest that Mediclinic International is progressively becoming less dependent on debt to grow their business.

Mediclinic International LT-Debt-to-Total-Asset Historical Data

The historical data trend for Mediclinic International's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mediclinic International LT-Debt-to-Total-Asset Chart

Mediclinic International Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.26

0.28

0.34

0.33

0.34

Mediclinic International Semi-Annual Data
	Mar13	Sep13	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.35	0.33	0.34	0.34	0.32

Mediclinic International LT-Debt-to-Total-Asset Calculation

Mediclinic International's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2022 is calculated as

LT Debt to Total Assets (A: Mar. 2022 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2022 )	/	Total Assets (A: Mar. 2022 )
	=	3185.771	/	9495.389
	=	0.34

Mediclinic International's Long-Term Debt to Total Asset Ratio for the quarter that ended in Sep. 2022 is calculated as

LT Debt to Total Assets (Q: Sep. 2022 )	=	Long-Term Debt & Capital Lease Obligation (Q: Sep. 2022 )	/	Total Assets (Q: Sep. 2022 )
	=	2867.497	/	8926.387
	=	0.32

Mediclinic International (OTCPK:ANHGY) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Mediclinic International LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Mediclinic International's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Mediclinic International (Mediclinic International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mediclinic International PLC (OTCPK:ANHGY) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.mediclinic.com

Mediclinic International PLC is a UK based international private healthcare group. It is engaged in offering acute care, specialist-orientated and multi-disciplinary healthcare services, by operating many hospitals and clinics. The geographic operating segments of the company are Mediclinic Southern Africa, Mediclinic Switzerland, and Mediclinic Middle East. It derives the majority of the revenue from the Switzerland segment. The other non-operating segments of the company are the United Kingdom and Corporate. The group's operations are carried out under the Mediclinic and Hirslanden brand.